1. ASHP Guidelines on handling hazardous drugs. Développé par le ASHP Council on professional affairs et approuvé par le conseil d’administration de l’ASHP le 12 janvier 2006. Am J Health-Syst Pharm. 2006;63:1172-93.
Télécharger le document
2. Department of health and human service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health. NIOSH ALERT Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings.
Publication NIOSH N° 2004-165 Sep 2004.
Télécharger le document
3. Connor T, Shults M, Fraser M. Determination of the vaporization of solutions of mutagenic antineoplastic agents at 23 and 37°C using a desiccator technique. Hospital Pharmacy, Vol. 34 N°. 11, Nov 1999, 85-92.
Résumé
4. Sessink PJM, Bos RP. Drugs Hazardous to Healthcare Workers (Evaluation of Methods for Monitoring Occupational Exposure to Cytostatic Drugs) A Review Article. Drug Safety, 1999, Apr: 20 (4) 347-359.
Résumé
5. Connor T, Anderson R, Sessink PJM, Broadfield L, Power L. Surface contamination with antineoplastic agents in six cancer centers in Canada and the United States. AJHP Vol 56 Jul 15 1999, 1427-1432.
Résumé
6. Minioia C, Turci R, Sotannie C, et al. Application of High Performance Liquid Chromatography/Tandem Mass Spectrometry in the Environmental and Biological Monitoring of Health Care Personnel Occupationally Exposed to Cyclophosphamide and Ifosfamide. Rapid Commun. Mass Spectrom. 12, 1485-1493 (1998).
Résumé
7. Opiolka S, Molter W, Goldschmidt R, Erich E, Schoppe G. Evaporation of cytostatic drugs during preparation. Gefahrstoffe-Reinhaltung der Luft 58 (1998) Nr. 7/8-July/August.
Résumé
8. Baker E, Connor T. Monitoring occupational exposure to cancer chemotherapy drugs. A Review Article. AJHP 53 Nov 15 1996, 2713-2723.
Résumé
9. Sessink PJM, Boer KA, Scheefhals APH, et al. Occupational exposure to antineoplastic agents at several departments in a hospital. Int Arch Occup Environ Health (1992) 64:105-112.
Résumé
